Alerts will be sent to your verified email
Verify Email
MAHAREM
|
IndoAmerican Advance
|
Auro Laboratories
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.31 % | 12.83 % | 16.56 % |
|
5yr average Equity Multiplier
|
1.07 | 1.84 | -1.71 |
|
5yr Average Asset Turnover Ratio
|
0.15 | 0.8 | 1.26 |
|
5yr Avg Net Profit Margin
|
-36.65 % | 9.49 % | -10.07 % |
|
Price to Book
|
n/a | 3.99 | 0.0 |
|
P/E
|
n/a | 58.83 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 80.24 Days | -21.7 Days |
|
Inventory Days
|
0.0 | 56.39 Days | 80.38 Days |
|
Days Receivable
|
0.0 | 214.37 Days | 20.8 Days |
|
Days Payable
|
167.71 Days | 115.48 Days | 154.17 Days |
|
5yr Average Interest Coverage Ratio
|
-55.68 | 10.53 | -3.16 |
|
5yr Avg ROCE
|
-12.15 % | 16.02 % | -3.19 % |
|
5yr Avg Operating Profit Margin
|
-72.03 % | 15.11 % | -9.3 % |
|
5 yr average Debt to Equity
|
0.0 | 0.48 | -1.91 |
|
5yr CAGR Net Profit
|
n/a | -23.84 % | n/a |
|
5yr Average Return on Assets
|
-11.02 % | 7.53 % | -6.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.97 % | 52.18 % | 55.93 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.4 % | 0.09 % | 43.6 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.04 % |
|
IndoAmerican Advance
|
Auro Laboratories
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|